Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-039925
Filing Date
2021-06-11
Accepted
2021-06-11 17:11:29
Documents
2
Period of Report
2021-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5701
2 POA DOCUMENT poa.txt EX-24.4_992251 1769
  Complete submission text file 0001209191-21-039925.txt   8785
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 707 WALCOTT WAY CARY NC 27519
Business Address
Pavliv Leo (Reporting) CIK: 0001408593 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 211012241